Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083270 | SCV000166301 | benign | Gorlin syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121884 | SCV000514297 | benign | not specified | 2015-09-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000492416 | SCV000581043 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001166906 | SCV001329331 | benign | Holoprosencephaly 7 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001083270 | SCV001329332 | benign | Gorlin syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Institute for Clinical Genetics, |
RCV000034563 | SCV002011174 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000492416 | SCV002526843 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-11 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121884 | SCV002765999 | likely benign | not specified | 2022-11-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000121884 | SCV002773933 | benign | not specified | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034563 | SCV004160203 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | PTCH1: BS1 |
Breakthrough Genomics, |
RCV000034563 | SCV005222453 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Biesecker Lab/Clinical Genomics Section, |
RCV000034563 | SCV000043457 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
ITMI | RCV000121884 | SCV000086086 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV000034563 | SCV001799470 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000034563 | SCV001807086 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000034563 | SCV001975539 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004549397 | SCV004753745 | likely benign | PTCH1-related disorder | 2020-09-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |